SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-037634
Filing Date
2020-02-14
Accepted
2020-02-14 13:43:05
Documents
1
Group Members
SC U.S. VENTURE XIV MANAGEMENT, L.P.SC US (TTGP), LTD.SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XIV (Q), L.P.SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XIV, L.P.SEQUOIA CAPITAL USV XIV HOLDCO, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d879468dsc13ga.htm SC 13G/A 106921
  Complete submission text file 0001193125-20-037634.txt   108676
Mailing Address 2800 SAND HILL RD, SUITE 101 MENLO PARK CA 94025
Business Address 2800 SAND HILL RD, SUITE 101 MENLO PARK CA 94025 650-854-3927
SEQUOIA CAPITAL U.S. VENTURE FUND XIV, L.P. (Filed by) CIK: 0001556027 (see all company filings)

IRS No.: 981069306 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Subject) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90826 | Film No.: 20617596
SIC: 8071 Services-Medical Laboratories